$BRKR Cashflow Statement | Understand Stock

$BRKR

$60.74 +$2.51 (4.31%) Close

$BRKR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Consolidated net (loss) income
Adjustments to reconcile consolidated net (loss) income to cash flows from operating activities:
Depreciation and amortization
Stock-based compensation expense
Deferred income taxes
Bargain purchase gain on acquisition and associated measurement period adjustments
Impairment of minority investments and other long-lived assets
Loss on sale of minority investment
Gain (loss) on sale of property, plant and equipment
Impairment of goodwill, intangible assets, other long-lived assets, and certain minority investments
Write down of inventories
Acquisition-related hybrid liability adjustments
Foreign currency transaction (gain) loss, net
Other non-cash expenses, net
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable
Inventories
Accounts payable and accrued expenses
Accounts payable
Accrued compensation
Income taxes payable, net
Deferred revenue and customer advances
Customer advances
Other changes in operating assets and liabilities, net

Net cash provided by operating activities
Cash flows from investing activities:
Purchase of short-term investments
Maturity of short-term investments
Purchase of investments held to maturity
Proceeds from sale of minority investment
Cash paid for minority investments
Cash paid for business combinations, net of cash acquired
Proceeds from sales of property, plant and equipment
Net proceeds from cross-currency swap agreements
Cash paid for in-process research and development and related assets
Other investing activities, net
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from issuance (repayment) of long-term debt
Repayment of 2012 Note Purchase Agreement
Repayment of 2019 Term Loan Agreement
Repayments of revolving lines of credit
Proceeds from revolving lines of credit
Proceeds (repayment) of other debt, net
Repayment of long-term debt
Proceeds from long-term debt
Payment of deferred financing costs
Proceeds from Public Offering of common stock, net of issuance costs
Proceeds from issuance of Series A Mandatory Convertible Preferred Stock, net of issuance costs
Proceeds from issuance of common stock, net
Payment of contingent consideration
Payment of dividends to Series A Mandatory Convertible Preferred Shareholders
Payment of dividends to common shareholders
Repurchase of common stock
Proceeds from the sale (payment for the purchase) of noncontrolling interests
Other financing activities, net
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Supplemental cash flow information:
Cash paid for interest
Cash paid for taxes
Restricted cash period beginning balance
Restricted cash period ending balance

Comments